Parkinson's Trial NCT06320639
Driving simulator improves driving safety
- Trial ID
- NCT06320639
- Official Title
- Driving Simulator and People With Neurocognitive Disorders
- Goal
- Driving simulator improves driving safety
- Status
- RECRUITING
- Sponsor
- University Gustave Eiffel
- Study Type
- OBSERVATIONAL
- Enrollment
- 150 participants
- Conditions
- Neurocognitive Disorders
Summary For Families
They want to clarify how neurocognitive disorders affect real-world driving skills, so clinicians can better identify specific driving errors and safety risks. Participants drive in a realistic simulator while researchers measure things like lane keeping, reaction time, braking and hazard response, and record collisions, this is purely observational and not testing a drug or device. The trial seeks 50 to 95-year-olds diagnosed with a DSM-V neurocognitive disorder who have a B license with 3+ years driving experience and are active drivers or stopped less than two months ago, with normal or corrected vision and appropriate consent or a legal representative; people with epilepsy, vestibular problems or severe motion sickness, certain psychiatric histories or unstable psychiatric medications, recent alcoholism, use of anti-epileptics, or major walking-limiting joint problems are excluded.
Locations
- Hôpital des Charpennes, Villeurbanne, France
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. They want to clarify how neurocognitive disorders affect real-world driving skills, so clinicians can better identify specific driving errors and safety risks. Participants drive in a realistic simulator while researchers measure things like lane keeping, reaction time, braking and hazard response, and record collisions, this is purely observational and not testing a drug or device. The trial seeks 50 to 95-year-olds diagnosed with a DSM-V neurocognitive disorder who have a B license with 3+ years driving experience and are active drivers or stopped less than two months ago, with normal or corrected vision and appropriate consent or a legal representative; people with epilepsy, vestibular problems or severe motion sickness, certain psychiatric histories or unstable psychiatric medications, recent alcoholism, use of anti-epileptics, or major walking-limiting joint problems are excluded.
- Who can participate?
- Participants must be between 50 Years and 95 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 3 years.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.